United States · FDA National Drug Code directory
Sylvant
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73090-421_c32bb83e-f9f4-4a6e-928a-f736138996b6
- Product NDC
- 73090-421
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- Siltuximab
- Labeler
- Recordati Rare Diseases, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20140423
- Source listing expiry
- 20261231
Source-listed ingredients
- SILTUXIMAB — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 BOX (73090-421-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE · 73090-421-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →